HSS Extends Global Network to Colombia with New Collaboration

NEW YORK, Dec. 9, 2019 /PRNewswire/ — HSS, the world’s leading academic medical center focused on musculoskeletal health headquartered at Hospital for Special Surgery in New York, today announced a strategic collaboration with Centro Hospitalario Serena del Mar, the medical center operated by Fundación Santa Fe de Bogotá within the visionary city Serena del Mar on the north coast of Cartagena, Colombia. Through a ‘medical bridge’ HSS will provide CHSM with specialist knowledge, training, best practice protocols and access to diagnostic support that will help ensure the highest possible standards of clinical quality and experience for patients from Central and South America.

Specialized in advancing orthopedics, rheumatology and related disciplines for 156 and ranked No. 1 in the U.S. for orthopedics for the 10 consecutive years by U.S. News & World Report, HSS expertise is recognized globally. Its Continuing Medical Education and other forms of training are the choice of professionals in 130 countries, and patients from more than 100 countries travel to HSS for care. As the world’s leading and largest laboratory for research in the fields of orthopedics and rheumatology, HSS advancements have included invention of the first modern total knee replacement and discoveries that led to an FDA approved therapy for rheumatoid arthritis.

To extend the availability and impact of its expertise, HSS collaborates strategically with select, like-minded organizations worldwide. Together, these collaborations work to transform care through innovation and the creation of a culture of excellence via continuous knowledge transfer, education and process improvement.  

“HSS has the privilege and responsibility to advance care and quality of life everywhere, and collaboration with other organizations committed to excellence is proving to be a very effective strategy,” said Louis A. Shapiro, president and CEO of HSS. “Serena del Mar, and its Central Hospital supported HSS, promise to have an outsized impact on quality of life in that part of the world.” 

Serena del Mar is a new city constructed 12 km from the old city port of Cartagena, which offers residents opportunities for an enriched quality of life. Designed by innovative developers, planners, and landscapers, Serena del Mar will provide residents with offerings such as primary and higher education systems, economic opportunities, recreational green spaces and CHSM.

“At Serena del Mar, we have created a co-mingling of culture and innovation,” said Daniel Haime, president of Serena del Mar. “We wanted to provide residents with everything they may need including the best orthopedic care. HSS is in a class of its own, and its presence in our community will enhance our residents’ health and well-being.”

CHSM is operated by Fundación Santa Fe de Bogotá; its orthopedics department will be affiliated with HSS. In this new collaboration, HSS will provide musculoskeletal-related clinical services, as well as recommendations for facility design, including enhancements to improve operating room efficiency.

CHSM is expected to open in January 2020.

About HSS

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the tenth consecutive year), No. 3 in rheumatology by U.S. News & World Report (2019-2020), and named a leader in pediatric orthopedics by U.S. News & World Report “Best Children’s Hospitals” list (2019-2020). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In addition, HSS will be opening a new facility in Florida in early 2020. In 2018, HSS provided care to 139,000 patients and performed more than 32,000 surgical procedures, and people from all 50 U.S. states and 80 countries traveled to receive care at HSS. There were more than 37,000 pediatric visits to the HSS Lerner Children’s Pavilion for treatment by a team of interdisciplinary experts. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is the world’s leading provider of education on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.

SOURCE Hospital for Special Surgery

Related Links


Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as Chief Executive Officer of Surgio Health as well as COO at Ortho Spine Partners. Chris has close to 20 years of healthcare management experience with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that solve real problems that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help drive better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button